3 completed, 2 unknown, 1 active not recruiting, 1 terminated. 7 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 3, Unknown 2, Active not recruiting 1, Terminated 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Magnetic Resonance Imaging: new trials by email Literature Review of Magnetic Resonance Imaging trials Research Report on Magnetic Resonance Imaging
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Nutritional Ketosis on Alcohol Metabolism Ketone Supplement, Control Diet, Ketogenic diet - Ketoses, Metabolic, Ketogenic Dieting | Phase 2 / Phase 3 | Active not recruiting | University of Pennsylvania | 23 | 2024-02-29 | 2026-04-07 |
| Preventive VT Substrate Ablation in Ischemic Heart Disease Ventricular tachycardia substrate-based radiofrequency ablation - Ventricular Tachycardia, Ventricular Arrythmia | Phase 3 | Unknown | Centro Medico Teknon | 58 | 2021-06-01 | 2023-08-30 |
| Study to Evaluate the Optimal Dose of Remifentanil During MRI of the Heart Under General Anaesthesia Remifentanil and/or propofol, propofol - Children, Heart Diseases | Phase 3 | Unknown | Alder Hey Children's NHS Foundation Trust | 35 | 2015-07-01 | 2019-01-10 |
| Magnetic Resonance Imaging of the Liver in Children 0-2 Months of Age With an Intravenous Injection of Eovist/Primovist Which is a Contrast Agent Gadoxetate disodium (Eovist/Primovist, BAY86-4873) - Magnetic Resonance Imaging | Phase 3 | Terminated | Bayer | 1 | 2015-02-01 | 2016-09-23 |
| Safety and Efficacy of Gadobutrol 1.0 Molar in Japanese Subjects for CNS Imaging Gadobutrol (Gadovist, BAY86-4875) - Magnetic Resonance Imaging | Phase 3 | Completed | Bayer | 223 | 2012-09-01 | 2014-10-01 |
| Contrast-enhanced MRI in Children 2 Months to <2 Years Gadopentetate dimeglumine (Magnevist, BAY86-6661) - Magnetic Resonance Imaging | Phase 3 | Completed | Bayer | 54 | 2010-01-01 | 2015-11-18 |
| Gadobutrol Magnevist-controlled Body Study Gadobutrol (Gadovist, BAY86-4875), Gadopentetate Dimeglumine (Magnevist, BAY86-4882) - Magnetic Resonance Imaging | Phase 3 | Completed | Bayer | 370 | 2010-01-01 | 2014-12-30 |
Alcohol Drinking (1) · Alcoholic Intoxication (1) · Death, Sudden, Cardiac (1) · Heart Diseases (1) · Ketosis (1) · Myocardial Infarction (1) · Myocardial Ischemia (1) · Neoplasms (1) · Tachycardia, Ventricular (1)
Cardiovascular Diseases (2) · Acid-Base Imbalance (1) · Acidosis (1) · Alcohol-Related Disorders (1) · Arrhythmias, Cardiac (1) · Behavior (1) · Cardiac Conduction System Disease (1) · Chemically-Induced Disorders (1) · Death (1) · Death, Sudden (1) · Drinking Behavior (1) · Heart Arrest (1) · Heart Diseases (1) · Infarction (1) · Ischemia (1)
Gadolinium DTPA (2) · gadobutrol (2) · Diet, Ketogenic (1) · Ethanol (1) · Propofol (1) · gadolinium ethoxybenzyl DTPA (1)
Bayer (4) · Alder Hey Children's NHS Foundation Trust (1) · Centro Medico Teknon (1) · University of Pennsylvania (1)
United States (3) · Japan (2) · China (1) · Germany (1) · South Korea (1) · Spain (1) · United Kingdom (1)
Antonio Berruezo, MD, PhD (1) · Corinde Wiers, Ph.D. (1) · Henry Kranzler, MD (1) · Kyle Kampman, MD (1)
2009 (1), R21AA031088 (1)